Skip to main content

WPI 844 Pill - orange round, 6mm

Pill with imprint WPI 844 is Orange, Round and has been identified as Glipizide Extended Release 5 mg. It is supplied by Watson Laboratories, Inc.

Glipizide is used in the treatment of Diabetes, Type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 844

Glipizide extended release 5 mg WPI 844
Glipizide extended release 5 mg WPI 844 Front
Glipizide extended release 5 mg WPI 844 Back
Glipizide extended release 5 mg WPI 844

Glipizide Extended Release

WPI 844
5 mg
6.00 mm
Prescription only
Drug Class
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
Inactive Ingredients
acetyltributyl citrate, ammonia, butyl alcohol, ferrosoferric oxide, hydroxyethyl cellulose (2000 mpa.s at 1%), isopropyl alcohol, lactose monohydrate, magnesium stearate, methacrylic acid - methyl methacrylate copolymer (1:1), polyethylene glycol 400, propylene glycol, shellac, FD&C Yellow No. 6

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-0844 Watson Pharmaceuticals, Inc.
68084-0111 Amerisource Health Services
10370-0190 (Discontinued) Anchen Pharmaceuticals, Inc.
54569-5547 A-S Medication Solutions, LLC (repackager)
54868-5210 (Discontinued) Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Related images for "WPI 844"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.